Journal Title：American Journal Of Respiratory And Critical Care Medicine

The American Journal of Respiratory and Critical Care Medicine focuses on human biology and disease, as well as animal and in vitro studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients.

Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish clinical trials and outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Critical Care Perspectives or Pulmonary Perspectives. These are generally focused on a more limited area and advance a concerted opinion about care for a specific process. Concise Clinical Reviews provide an evidence-based synthesis of the literature pertaining to topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. Images providing advances or unusual contributions to the field are published as Images in Pulmonary, Critical Care, Sleep Medicine and the Sciences.

《美國呼吸與重癥監(jiān)護(hù)醫(yī)學(xué)雜志》專注于人類生物學(xué)和疾病，以及動物和體外研究，這些研究有助于了解影響呼吸系統(tǒng)和重癥患者的疾病的病理生理學(xué)和治療。

完全或主要基于細(xì)胞和分子生物學(xué)的論文發(fā)表在姊妹雜志《美國呼吸細(xì)胞和分子生物學(xué)雜志》上。該雜志還尋求以多種形式發(fā)表臨床試驗(yàn)和感興趣的領(lǐng)域的優(yōu)秀評論文章。最新評論是一篇論文，通常涵蓋廣泛的領(lǐng)域，將基礎(chǔ)研究帶到床邊。較短的評論以《重癥監(jiān)護(hù)觀點(diǎn)》或《肺部觀點(diǎn)》的形式發(fā)表。這些通常側(cè)重于更有限的領(lǐng)域，并就特定過程的護(hù)理提出一致的看法。簡明臨床評論提供了與肺部、重癥監(jiān)護(hù)和睡眠醫(yī)學(xué)實(shí)踐中至關(guān)重要的主題相關(guān)的文獻(xiàn)的循證綜合。為該領(lǐng)域提供進(jìn)展或獨(dú)特貢獻(xiàn)的圖像將以《肺部、重癥監(jiān)護(hù)、睡眠醫(yī)學(xué)和科學(xué)圖像》的形式發(fā)表。

American Journal Of Respiratory And Critical Care Medicine創(chuàng)刊于1994年，由American Thoracic Society出版商出版，收稿方向涵蓋醫(yī)學(xué) - 呼吸系統(tǒng)全領(lǐng)域，在行業(yè)領(lǐng)域中學(xué)術(shù)影響力很大，屬于TOP期刊，國際一流期刊，關(guān)注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關(guān)注此刊。平均審稿速度 一般,3-6周 ，影響因子指數(shù)19.3，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。